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Loss-of-function mutations in TTC19 (tetra-tricopep-
tide repeat domain 19) have been associated with
severe neurological phenotypes and mitochondrial
respiratory chain complex III deficiency. We previ-
ously demonstrated the mitochondrial localization
of TTC19 and its link with complex III biogenesis.
Here we provide detailed insight into the mechanistic
role of TTC19, by investigating a Ttc19/ mouse
model that shows progressive neurological and
metabolic decline, decreased complex III activity,
and increased production of reactive oxygen spe-
cies. By using both the Ttc19/ mouse model and
a range of human cell lines, we demonstrate that
TTC19 binds to the fully assembled complex III
dimer, i.e., after the incorporation of the iron-sulfur
Rieske protein (UQCRFS1). The in situ maturation
of UQCRFS1 produces N-terminal polypeptides,
which remain bound to holocomplex III. We show
that, in normal conditions, these UQCRFS1 frag-
ments are rapidly removed, but when TTC19 is
absent they accumulate within complex III, causing
its structural and functional impairment.
INTRODUCTION
Complex III, or ubiquinol:cytochrome c oxidoreductase, is the
central complex in the mitochondrial electron transport chain.
Complex III is a multi-heteromeric enzyme, organized in a
symmetrical dimeric structure (cIII2) of 480 kDa (Iwata et al.,
1998). cIII2 catalyzes the transfer of electrons from Coenzyme
Q to cytochrome c, while pumping protons from the matrix to
the intermembrane space. In yeast and birds, the cIII monomer
is composed of ten different subunits, whereas an eleventh sub-
unit, Subunit 9 (Su9) in the bovine nomenclature, has been iden-
tified in mammals as a post-translational proteolytic product
consisting of the 78-amino acid-long N-terminal mitochondrial96 Molecular Cell 67, 96–105, July 6, 2017 ª 2017 Published by Elsetargeting sequence (MTS) of the 2Fe-2S cluster-containing
Rieske protein, encoded by the UQCRFS1 gene (Brandt et al.,
1993). Cytochrome b (MT-CYB), the only cIII2 component en-
coded by mtDNA, is one of the three catalytic subunits of the
complex, and it contains a low-potential (bL) and a high-potential
(bH) heme b moieties as prosthetic groups. Of the other ten sub-
units, encoded by nine nuclear genes, two play a catalytic role:
the UQCRFS1 Rieske protein and cytochrome c1, encoded by
CYC1, which contains a c-type heme group. The role of the other
eight supernumerary subunits remains unclear.
Although cIII2 assembly has been less intensively investigated
compared to other respiratory complexes, in the last few years
the study of yeast mutant models has provided some insight into
this process (Gruschke et al., 2012; Hildenbeutel et al., 2014;
Smith et al., 2012; Zara et al., 2009). Studies on cIII2-associated
human diseases have confirmed that some cIII2 assembly steps
are similar to yeast, especially the late ones. Based on the yeast
model, cIII2 assembly starts with the insertion into the inner mito-
chondrial membrane of MT-CYB, bound to chaperones UQCC1,
UQCC2, and UQCC3. These chaperones are released during the
sequential incorporation of additional subunits into an inactive
dimericpre-cIII2,which iseventuallyactivatedby the incorporation
of the last subunits, UQCRFS1 and UQCR11. This final step, i.e.,
the UQCRFS1 incorporation, is mediated by BCS1L, the most
extensively characterized cIII2 assembly factor, and LYRM7
(MZM1L), a matrix protein that stabilizes the subunit before its
assembly into cIII2 (Fernández-Vizarra and Zeviani, 2015).
Pathogenic mutations have been found in some of cIII2-related
ancillary factors, including BCS1L (de Lonlay et al., 2001; Fellman,
2002; Fernandez-Vizarra et al., 2007; Hinson et al., 2007; Morán
et al., 2010; Ramos-Arroyo et al., 2009), TTC19 (Ardissone
et al., 2015; Atwal, 2014; Ghezzi et al., 2011; Kunii et al., 2015;
Melchionda et al., 2014; Mordaunt et al., 2015; Morino et al.,
2014; Nogueira et al., 2013), LYRM7 (Dallabona et al., 2016;
Invernizzi et al., 2013), UQCC2 (Tucker et al., 2013), and
UQCC3 (Wanschers et al., 2014). In particular, mutations in
TTC19 have been identified in patients with heterogeneous,
but invariably severe, phenotypes, including early-onset, slowly
progressive encephalomyopathy; adult-onset, rapidly progres-
sive multisystem neurological failure; adult-onset spinocerebellar
ataxia; and childhood or juvenile spinocerebellar ataxia withvier Inc.
Figure 1. Clinical Characterization of 6-Month-Old Ttc19–/– Mice
(A) Body weights of Ttc19/ versus Ttc19WT littermates (combined Ttc19+/ and Ttc19+/+ individuals), n = 8–11 animals/group; (B) feet clasping reflex (normal
reflex is in abduction, here the lower limbs are tightly adducted), (C) rotarod test, n = 6–8 animals/group, average of three trials/mouse; (D) cylinder test, n = 6–9
animals/group, average of two trials/mouse; (E) pole test, n = 6–9 animals/group, average of five trials/mouse; (F) negative geotaxis test, n = 6–9 animals/group,
average of two trials/mouse; and (G) treadmill test, n = 6–11 animals/group. Error bars represent SEM; statistical analysis was by unpaired Student’s t test (*p <
0.05, **p < 0.01, and ***p < 0.005; n.s., not significant). Red bars, Ttc19WT; blue bars, Ttc19/. See also Figures S2 and S3.psychosis (OMIM: 613814). TTC19 encodes the precursor of the
tetratricopeptide repeat domain 19 protein. TTC19, a 380-amino
acid-long polypeptide, is addressed to mitochondria by a 70-
amino acid-long MTS, which is removed after translocation of
the protein into the inner mitochondrial compartment. Mature
human TTC19 is a 35-kDa protein embedded within the inner
mitochondrial membrane, with orthologs in multicellular animals
but neither in fungi nor in plants. Unlike other assembly factors,
TTC19 binds to mature dimeric cIII2, whereas, in mutant human
fibroblasts, its absence leads to the accumulation of lower
molecular weight species-containing cIII2 subunits, UQCRC1
and UQCRC2 (Ghezzi et al., 2011). Here we present a study
that elucidates the molecular role of TTC19 by investigating
human cell and mouse animal models.
RESULTS
Clinical Characterization of Ttc19–/– Mice
We created a constitutive Ttc19/ mouse by gene targeting
(Figure S1). The gender and genotype distribution at birth wascompatible with a mendelian autosomal recessive trait and no
evidence of embryonic lethality. At 6 months of age, both
Ttc19/ males and females showed a reduction in body weight
compared to wild-type (WT) littermates (Figure 1A). No differ-
ences were observed between Ttc19+/+ and Ttc19+/ animals
for any of the parameters investigated; therefore, both geno-
types were considered as controls (Ttc19WT). Several tests
were used to assess neurological, behavioral, and metabolic
features. At 6 months of age, Ttc19/ mice showed a patholog-
ical feet-clasping reflex (Figure 1B), and they scored significantly
less than WT littermates in rotarod, cylinder, negative geotaxis,
and pole tests, which measure motor coordination, exploratory
behavior, general proprioception, and motor planning skills,
respectively (Figures 1C–1F). Motor endurance, assessed by
standard treadmill test, was also reduced in Ttc19/ versus
Ttc19WT animals (Figure 1G). Some of these features were
already present at 3 months of age (Figure S2). No differences
in lifespan were observed up to 21 months (data not shown).
To study whole-body metabolism, we used a comprehensive
lab animals monitoring system (CLAMS). Ttc19/ femalesMolecular Cell 67, 96–105, July 6, 2017 97
Figure 2. Respiratory Chain Activities and
Hydrogen Peroxide Production in Ttc19–/–
Tissues
(A) Spectrophotometric analysis of biochemical
activities of mitochondrial respiratory chain com-
plexes normalized to CS activity and expressed as
percentage compared to control values (n = 4
mice/group, age = 3 months old).
(B–D) Time course analysis of H2O2 production
measured by Amplex Red in isolated mitochon-
dria, without the addition of external substrates or
inhibitors, for (B) liver, (C) heart, and (D) skeletal
muscle. Error bars represent SEM; statistical
analysis was by unpaired Student’s t test (*p <
0.05, **p < 0.01, and ***p < 0.005). Blue lines,
Ttc19/ samples; red lines, Ttc19WT samples;
n = 3 animals/group in duplicate.showed reduced food and water intake compared to Ttc19WT
female littermates (Figures S3A and S3B); VO2 consumption
and VCO2 production were significantly reduced in Ttc19
/
versus Ttc19WT animals of both sexes (Figures S3C and S3D);
accordingly, energy expenditure, measured as the ratio between
heat rate and body weight, was decreased (Figure S3E),
although statistical significance was achieved only in females.
Likewise, the respiratory exchange ratio (RER) was significantly
reduced in females, suggesting increased utilization of fat versus
carbohydrates to produce energy (Figure S3F). Total, ambula-
tory, and rearing movements were significantly decreased in
Ttc19/ versus Ttc19WT littermates of both genders (Fig-
ure S3G). These data indicate neurological impairment and
reduction in energy metabolism of Ttc19/ mice.
Neuropathology of Ttc19–/– Mice
Extensive astrogliosis, most often surrounding dilated vascular
structures (FiguresS4A andS4C), and the accumulation of ubiqui-
tinated proteins in neurons (Figure S4E) were detected in the
thalamus of all Ttc19/ mice analyzed (n = 6), suggesting an
ongoing brain injury. These featureswere not observed inTtc19WT
littermates (n = 6) (Figures S4B, S4D, and S4F). No abnormalities
were detected in skeletal muscle by H&E (data not shown). Light
microscopy of brain sections stained by H&E (data not shown)
or Nissl (Figure S4G) did not reveal obvious neuronal loss,
compared to Ttc19WT brain (Figure S4H). No sign of neurodegen-
eration or apoptosis was detected by staining brain sections with
fluorojade C or terminal deoxynucleotidyl transferase (TdT) dUTP
nick-end labeling (TUNEL) (data not shown).
Biochemical Analysis of Ttc19–/– Tissues
Similar to human patients, Ttc19 ablation in mice caused cIII2
deficiency in all tested tissues. At 3 and 6months of age, cIII2/cit-
rate synthase (CS) activity was significantly reduced (z50%,
p<0.005) in brain, liver, andskeletalmuscle fromTtc19/ versus98 Molecular Cell 67, 96–105, July 6, 2017Ttc19WT (Figure 2A), with no gender differ-
ences. The residual activity was further
reduced (z40%) at 18 months in both
females and males (data not shown).
Defective cIII2 activity is associated withincreased production of reactive oxygen species (ROS) (Diaz
et al., 2012; Hinson et al., 2007), through reverse electron transfer
from reduced heme bL (Borek et al., 2008; Dröse and Brandt,
2008). Accordingly, H2O2 production in isolated mitochondria
from liver, heart, and skeletal muscle was significantly higher in
Ttc19/ compared to Ttc19WT littermates (Figures 2B–2D).
Analysis of cIII2 Assembly in Ttc19
–/– Tissues
Next, the assembly of cIII2 in mitochondria isolated from mouse
brain, liver, and skeletal muscle was investigated by blue native
gel electrophoresis (BNGE). First dimension (1D)-BNGE revealed
an altered electrophoretic pattern in the Ttc19/ samples from
all three tissues (Figure 3A), as the cIII2 bandmigratedmore slowly
and appeared blurred. The aberrant band was observed when
using either digitonin or dodecyl-maltoside (DDM) as solubilizing
detergents (Figure 3B). To further investigate this phenomenon,
we carried out complexome profiling of Ttc19/ versus Ttc19WT
isolated liver (data not shown) and brain mitochondria solubilized
with 1% DDM (Figure 3C). The 1D-BNGE lanes were excised in
50 slices, and each slice was analyzed by mass spectrometry. In
Ttc19/ mitochondria, cIII2 subunits were detected in an area
of the gel slightly wider and with higher apparent molecular
mass than cIII2 subunits fromTtc19
WTmitochondria. Interestingly,
a normal migration pattern was restored by adeno-associated
virus serotype 2/8 (AAV2/8)-mediated expression of human
6xHis-tagged wild-type TTC19 (hTTC19His6) in Ttc19/ mouse
liver mitochondria (Figure S5A), demonstrating that the electro-
phoretic aberrationswerespecifically due to theabsenceofTtc19.
No accumulation of cIII2 sub-assemblies was detected in mito-
chondria from Ttc19/ mouse tissues by either complexome
profiling (Figure 3C) or denaturing second dimension (2D)-BNGE
using antibodies against several subunits of cIII2 (Figure S5B).
Proteomic analysis of SDS-PAGE of the native BNGE band corre-
sponding to cIII2 or the immunocaptured cIII2 from Ttc19
WT in
comparison with Ttc19/ failed to show any difference in protein
Figure 3. Characterization of cIII2 in Ttc19
–/–
Tissues
(A) Immunovisualization of cIII2 in BNGE of mito-
chondria extracted from liver, muscle, and brain.
Anti-UQCRC1 and anti-SDH70 were used for cIII2
and cII visualization, respectively.
(B) Top: BNGE of Ttc19WT and Ttc19/ mitochon-
dria, solubilized with DDM or digitonin. Bottom: an
enlargement of the cIII2 band is shown.
(C) Complexome analysis of brain mitochondria
solubilized with 1% DDM and run on a 4%–12%
BNGE gel cut in 50 slices and individually analyzed
by mass spectrometry. Top: heatmap shows the
relative peptide intensity among the slices of the
indicated subunits. NDUFB5 of complex I and
COX5A of complex IV are shown to indicate no
differences in their migration. Bottom: profile of the
indicated nine complex III subunits is shown.
Complex III peak of Ttc19WT localizes in slice 18
whereas that of Ttc19/ appears at a higher MW.
(D) Western blot (WB) of the subunits in cIII2 bands
cut from 1D-BNGE and run on SDS-PAGE.
(E) WB on complex III2 bands denatured and run
on SDS-PAGE. The re-expression of TTC196His
mediated by AAV in the liver of Ttc19/ mice
restored the incorporation of intact UQCRFS1 in
cIII2.
See also Figure S5.composition between the two genotypes. However, when the
band corresponding to holocomplex cIII2 was isolated and run
through a denaturing SDS-PAGE and analyzed by western blot
immunodetection,we observed a reduction of incorporated intact
UQCRFS1 in Ttc19/ versus Ttc19WT mouse samples and the
accumulation of UQCRFS1 degradation products (Figure 3D).
Interestingly, the levels of intact UQCRFS1 incorporated into
cIII2 were restored in Ttc19
/ liver (Figure 3E) by expressing
hTTC19His6 with the AAV2/8-hTTC19His6 vector. These results
demonstrated a role for TTC19 in stabilizing cIII2, through a spe-
cific protective effect on UQCRFS1.
Kinetics of cIII2 Assembly and UQCRFS1 Incorporation
in Ttc19–/– Mouse Mitochondria
Next, we investigated the dynamics of incorporation of an
early-assembled cIII2 subunit, UQCRB, and of UQCRFS1. The
35S-labeled translation products were incubated with Ttc19/and Ttc19WT mouse liver mitochondria at
different times (15-, 30-, and 60-min
pulses); samples were then washed and
incubated for a further 2 hr (chase). The
incorporation into cIII2 of both UQCRB
and UQCRFS1 was not significantly
different between the Ttc19/ and
Ttc19WT samples (Figure S6). We then
cut the cIII2 band from the BNGE gel
and denatured and electrophoresed it
by SDS-PAGE. Radiolabeled UQCRFS1-
derived fragments, including 12, 8, and
4 kDa in size, were already evident after
a 15-min pulse in both Ttc19/ and
Ttc19WT mitochondria (Figures 4A and 4B). Densitometric anal-
ysis of intact UQCRFS1 versus fragmented UQCRFS1 showed
that fragmented UQCRFS1 persisted longer in Ttc19/
compared to Ttc19WT samples (Figures 4C and 4D). These re-
sults indicate that UQCRFS1 is physiologically proteolysed
once it is incorporated in cIII2, since fragmented species were
bound to cIII2 and present very early in both Ttc19
/ and
Ttc19WT samples, but their clearance was slowed down in
Ttc19/ versus Ttc19WT mitochondria (Figures 4C and 4D).
The percentage of mature, intact UQCRFS1 was lower in
Ttc19/ versus Ttc19WT at 60 and 180 min, although the differ-
ence was not statistically significant (p = 0.067) (Figure 4C).
We also analyzed the relative amounts of the UQCRFS1 frag-
ments at different time points. The amount of the 12- and 8-kDa
fragments progressively decreased over time, whereas the
4-kDa fragment was virtually unchanged for all the time points
of the experiment. However, the decrease in the amount ofMolecular Cell 67, 96–105, July 6, 2017 99
Figure 4. UQCRFS1-Derived Fragments Are
Cleared More Rapidly in the Presence of
TTC19
(A) Isolated mitochondria from Ttc19/ and
Ttc19WT (Ttc19+/) mouse liver were incubated with
35S-labeled UQCRFS1 at different times (15, 30,
and 60 min). After a 60-min incubation, mitochon-
dria were washed and the incubation continued for
another 2 hr (chase; 180 min total incubation time).
A fraction of the mitochondria was also incubated
for 60 min in the presence of a protease inhibitor
cocktail (P.I.). After the 1D-BNGE, the band corre-
sponding to cIII2 was cut, denatured, and run
through SDS-PAGE, together with the in vitro
labeled UQCRFS1 (precursor). The radioactive
signals were visualized by phosphor-imaging.
(B) Isolated mitochondria from Ttc19/ and
Ttc19+/+ (Ttc19WT) mouse liver were incubated with
35S-labeled UQCRFS1 at 15 and 45 min in the
absence or presence of protease inhibitor cocktail
(P.I.). After the 1D-BNGE, the band corresponding
to cIII2 was cut, denatured, and run through SDS-
PAGE, together with the in vitro labeled UQCRFS1
(precursor). The radioactive signals were visualized
by phosphor-imaging.
(C) The relative proportion of the UQCRFS1 frag-
ments versus the mature protein in the SDS-PAGE
was quantified by densitometry (ImageJ). The
percentage of the total UQCRFS1 signal for each
of the species, classified according to their
calculated molecular mass, in the Ttc19/ and
Ttc19WT samples during the time course shown in
(A) was plotted. Values are mean ± SEM of three
independent experiments. Statistical analysis was
by unpaired Student’s t test.
(D) The percentage of 12-kDa fragments remaining
in each time point (15, 30, 60, and 180 min) for
Ttc19/ and Ttc19WT were adjusted to an expo-
nential one-phase decay curve. Error bars repre-
sent SEM (n = 3); statistical analysis was by
unpaired Student’s t test (*p < 0.05).
(E) UQCRFS1 amino acid sequence coverage of
the peptides detected by mass spectrometry. The
analysis was performed in three biological repli-
cates for each genotype, separating the upper part
of the SDS-PAGE gel (area covering from 30 to
14 kDa; in green) and the lower part of the gel (from
14 kDa to the Coomassie blue front; in red).
See also Figure S6.both 12- and 8-kDa fragments was slower in the Ttc19/ versus
Ttc19WT samples (Figure 4C), and this difference was significant
for the 12-kDa fragment at 180 min (p = 0.02) (Figure 4D). The
reduced clearance of UQCRFS1 fragments over time can explain
their accumulation in steady-state conditions (Figure 3D), and it
suggests a specific role for TTC19 as a husbandry factor in the
turnover of damaged UQCRFS1within cIII2. Finally, we observed
reduced incorporation of UQCRFS1 in the presence of a general
protease inhibitor cocktail, indicating that proteolytic processing
is necessary for the correct insertion of this subunit into cIII2. The
action of proteases is also necessary for the clearance of the
UQCRFS1 fragments, because their relative amounts versus
mature UQCRFS1 remained the same as in the 15-min pulse
(Figure 4B).100 Molecular Cell 67, 96–105, July 6, 2017Identification of the UQCRFS1-Derived Fragments
To gain insight into the identity of the accumulated fragments
derived from UQCRFS1, we again electrophoresed the cIII2
band from three Ttc19WT and three Ttc19/ samples from liver
mitochondria. Each of the gel lanes were cut into slices and
analyzed by mass spectrometry after tryptic digestion. The gel
was divided into two sections, one encompassing the protein
species from 30 to 14 kDa, where the mature UQCRFS1 is found
(calculated molecular weight [MW]: 21.5 kDa), whereas the sec-
ond one encompassed the interval from 14 kDa to the Coomas-
sie blue dye front of the gel, where theUQCRFS1 fragments were
detected. In the 30- to 14-kDa section, we consistently detected
tryptic peptides covering the full length of processed, mature
UQCRFS1, without the 78 N-terminal amino acid-long MTS
Figure 5. TTC19 Interacts with cIII2 and SC
(A and B) In organello import of 35S-labeled
hTTC19, hTTC196HIS, Uqcrfs1, and Uqcrb. Ttc19WT
and Ttc19/ mitochondria were solubilized in (A)
digitonin or (B) DDM and run on 1D-BNGE. Uqcrfs1
and Uqcrb were used for cIII2 visualization.
(C) Scatterplot showing proteins interacting with
hTTC19FLAG. The data were obtained by mass
spectrometry analysis of fractions from HEK293T
cells grown in SILAC media and immunoprecipi-
tated with anti-FLAG-conjugated agarose beads.
Each cell line was labeled with both heavy and
light amino acids. Before mitoplast generation
and solubilization, differentially labeled HEK cells
expressing hTTC19FLAG were combined with naive
cells in a 1:1 ratio. The values on the x axis come
from experiment 1, i.e., heavy-labeled hTTC19FLAG
HEK293T cells mixed with the light-labeled
naive cells, and the y axis represents the values
of experiment 2, i.e., light-labeled hTTC19FLAG
HEK293T cells mixed with the heavy-labeled naive
cells. Only the proteins showing a statistically
significant log2 enrichment ratio in both experi-
ments are plotted.
See also Figure S7 and Table S1.(Brandt et al., 1993). Conversely, in the 14 kDa-dye front section
of the gel, peptides corresponding to the MTS/Su9 were consis-
tently detected in both Ttc19WT and Ttc19/ samples, along
with other peptides corresponding to the rest of the UQCRFS1
sequence, with the exception of the C-terminal end (Figure 4D).
Physical Interaction of TTC19 with cIII2
To further characterize the proposed direct interaction of TTC19
with cIII2 (Ghezzi et al., 2011), we performed in organello im-
port experiments using in vitro translated 35S-labeled hTTC19
followed by BNGE. In digitonin-treated samples, we detected
35S-hTTC19 in bands corresponding to the cIII2 holocomplex
and cIII2-containing supercomplexes (SCs). Newly incorpo-
rated 35S-hTTC19 was detected only in Ttc19/, but not in
Ttc19WT, mitochondria, suggesting that the interaction of the
endogenous Ttc19 with cIII2 prevents its dislodgment by
35S-hTTC19. However, this interaction must be relatively labile,
since no 35S-hTTC19 signal was detected in mitochondria
treated with DDM, a detergent stronger than digitonin (Figures
5A and 5B).
To test whether the TTC19 migration in BNGE is due to its
physical interaction with cIII2, we then performed co-immuno-
precipitation assays using a HEK293T cell line expressing a
FLAG-tagged recombinant human TTC19 (hTTC19FLAG). We first
showed that hTTC19FLAG was robustly expressed in these cells
upon doxycycline induction (Figure S7A) and was co-immuno-
precipitated with UQCRFS1 and UQCRC2 (Figure S7B).
The protein interactions of hTTC19FLAG were further analyzed
by quantitative mass spectrometry analysis of mitoplasts from
naive and recombinant HEK293T cells after FLAG immunopurifi-
cation. Comparisons were enabled by stable isotopic labeling of
amino acids in cell culture (SILAC). From duplicate, reciprocal-
labeling experiments (see the STAR Methods for details), a total
of 64 proteins was quantitatively different in the hTTC19FLAGversus naive samples (Figure 5C; Table S1). Of these 64 proteins,
51 were components of the respiratory chain, including eight
subunits of cIII2, as well as numerous subunits of cI and cIV
(Table S1). These data demonstrate that hTTC19FLAG co-purifies
with cIII2 holocomplex, as well as with cIII2-containing SCs.
Interestingly, the mitochondrial proteases YME1L and PARL,
together with the scaffold protein STOML2 (SLP2), all three
members of the SPY complex (Wai et al., 2016), were also
co-immunopurified with TTC19, indicating physical interaction
(Table S1).
Kinetics of TTC19 Incorporation into cIII2
To explore the role of TTC19 in cIII2 biogenesis, we analyzed
three different cIII2-deficient cell lines: a TTC19-less human
fibroblast cell line (Ghezzi et al., 2011), two BCS1L-mutated
human fibroblast cell lines (Fernandez-Vizarra et al., 2007), and
a recombinant HeLa cell line overexpressing MZM1L/LYRM7HA
(Sánchez et al., 2013). The latter two cell lines showed a strong
reduction in the levels of UQCRFS1 present in cIII2 (Figure 6A),
since BCS1L is a late-stage assembly factor necessary
for UQCRFS1 incorporation (Fernandez-Vizarra et al., 2007),
whereas overexpression of LYRM7, which physically interacts
with UQCRFS1, causes UQCRFS1 to be sequestered in the
mitochondrial matrix, thus preventing its incorporation into cIII2
(Sánchez et al., 2013).
Immunodetection of 1D-BNGE (Figure 6A) and 2D-BNGE (Fig-
ure 6B) revealed that the lack of TTC19 did not prevent
UQCRFS1 from being incorporated into cIII2 and SC, since com-
parable levels were found in control and TTC19-less fibroblasts.
In addition, a substantial amount of TTC19 co-migrated with
cIII2, cIII2 + cIV, and SC in control cell lines (Figure 6B), confirm-
ing the data from quantitative mass spectrometry and in organ-
ello import. Conversely, in both BCS1L mutant and LYRM7HA-
overexpressing cells, TTC19 (Figure 6C) and residual UQCRFS1Molecular Cell 67, 96–105, July 6, 2017 101
Figure 6. TTC19 Interacts with cIII2 via
UQCRFS1
(A) 1D-BNGE and western blot analysis of digitonin-
treated immortalized skin fibroblasts from control
(CTR FB), TTC19-less (TTC19 FB), and BCS1L
mutant (BCS1L FB) cell lines, as well as HeLa cells
overexpressing LYRM7HA and its corresponding
empty vector control (HELA CTR). The blot was
immunodetectedusingananti-UQCRFS1antibody.
(B) A sample of BCS1L FB was run on a 2D-BNGE
and immunodetected with the indicated antibodies.
(C) A sample of HeLa cells overexpressing
LYRM7HA was run on a 2D-BNGE and immuno-
detected with the indicated antibodies.
(D) HEK293T cells were treated for 8 days with
15 mg/mL doxycycline and collected (t = 0 hr).
Doxycycline was then removed to let the mito-
chondrial respiratory chain assembly recover, and
cells were collected at the indicated times. Sam-
ples were run on a 2D-BNGE and immunodetected
with the indicated antibodies. Steady-state (ss)
level was used for comparison.were both present in SC, but they were virtually absent in free
cIII2 and cIII2 + cIV spots (Figures 6A and 6C).
Next, the kinetics of cIII2 assembly in control HEK293T cells
was investigated by treating them for 8 dayswith 15 mg/mL doxy-
cycline, a reversible inhibitor of mitochondrial translation (Mor-
eno-Lastres et al., 2012; Ugalde et al., 2004). After removal of
the drug, the incorporation of UQCRFS1, UQCRC2, and TTC19
into cIII2 was followed over time by immunodetection of 2D-
BNGE of digitonin-treated mitochondria. As shown in Figure 6D,
UQCRFS1 was incorporated later than UQCRC2 in cIII2-contain-
ing SC, cIII2-cIV, and cIII2 holocomplex, whereas TTC19 showed
the same kinetics of UQCRFS1.
Altogether these results indicate that TTC19 interacts with the
mature form of cIII2 (i.e., after UQCRFS1 incorporation) and is not
necessary for the incorporation of UQCRFS1 itself.102 Molecular Cell 67, 96–105, July 6, 2017DISCUSSION
Loss-of-function mutations in TTC19
have been found in patients with cIII2
deficiency associated with heteroge-
neous neurological syndromes (Ardis-
sone et al., 2015; Atwal, 2014; Ghezzi
et al., 2011; Kunii et al., 2015; Melchionda
et al., 2014; Mordaunt et al., 2015; Morino
et al., 2014; Nogueira et al., 2013). TTC19
ablation in D. melanogaster causes cIII2
deficiency associated with a neurological
phenotype in adult flies (Ghezzi et al.,
2011). Likewise, our Ttc19/ mice
showed slowly progressive impairment
of neurological skills; reduced energy
metabolism; and low cIII2 activity in brain,
liver, and skeletal muscle. These results
clearly indicate that TTC19 plays a role
in maintaining cIII2 integrity and function
in multicellular animals, thus preventingprogressive neurological impairment. As a consequence of cIII2
deficiency, especially when UQCRFS1 fails to be incorporated,
ROS production increases (Brand, 2010; Diaz et al., 2012; Hin-
son et al., 2007; Morán et al., 2010). This elevated oxidative
stress, which we have confirmed to occur in our Ttc19/
mouse, is likely to contribute to the pathology of the disease
associated to TTC19 mutations.
The availability of a constitutive Ttc19/mouse and of a set of
human cellular models allowed us to gain insight into the mech-
anism of action of TTC19. First, we demonstrated that Ttc19/-
associated cIII2 holocomplex displays an aberrant electropho-
retic behavior in Coomassie-stained BNGE. The altered mobility
and reduced focalization of cIII2-specific 1D-BNGE bands were
confirmed by complexome profiling of Ttc19/ mitochondria.
However, the subunit composition of cIII2 did not differ between
Figure 7. Late Steps of cIII2 Assembly in
Mammalian Mitochondria
Model depicting the last phase in cIII2 assembly
where UQCRFS1 is incorporated and processed
in situ. TTC19 is thenboundtomaturecIII2 toperform
its husbandry role in eliminating the N-terminal frag-
ments generated during UQCRFS1 assembly.Ttc19WT and Ttc19/ mitochondria, suggesting a subtler
change to the cIII2 structure rather than drastically impaired
cIII2 assembly. Second, in solid tissues of Ttc19
/ mice, we
detected reduced amounts of intact mature UQCRFS1 with
the accumulation of UQCRFS1-derived fragments. Our import
kinetic experiments show that UQCRFS1 processing occurs
rapidly after its assembly. The maturation of UQCRFS1 by pro-
cessing its precursor, through the cleavage of the N-terminal
78 amino acids, was found to occur in situ, once the protein is
incorporated into cIII2 (Brandt et al., 1993; Graham et al.,
1994). The MTS polypeptide was proposed to remain as a struc-
tural component of mammalian cIII2 and was identified as Su9
(Borchart et al., 1985; Brandt et al., 1993; Sch€agger et al.,
1985). In the bovine cIII2 X-ray diffraction structures, Su9 is found
between UQCRC1 and UQCRC2 (Iwata et al., 1998), which are
homologous to the two subunits of the matrix-processing pepti-
dase (MPP). They also possess protease activity that is inhibited
by the binding of UQCRFS1 N-terminal peptides (Deng et al.,
1998, 2001). According to the crystal structure, the proteolytic
site lies exactly between the N terminus of the mature UQCRFS1
and Su9. However, only a stretch of 33 amino acids of Su9 is
resolved in the 3-Å structure (Iwata et al., 1998).
We show here that several species (12, 8, and 4 kDa) are gener-
ated in UQCRFS1 maturation, most probably due to the endoge-
nous cIII2 MPP activity. We think that the cIII2-bound 8-kDa
fragment was purified in the experiments that led to the original
identification of Su9 (Borchart et al., 1985; Brandt et al., 1993;
Sch€agger et al., 1985); this peptide corresponds exactly to the
78 N-terminal amino acids of UQCRFS1. However, the identifica-
tion of this fragment does not necessarily imply that it must be
considered a structural subunit of cIII2, as we showed that
additional fragments from UQCRFS1 are also present in the
context of holo-cIII2. In fact, the results presented here clearly
show that there is a specific clearance of the 12- and 8-kDa frag-
ments, which is impaired in the absence of TTC19. In turn,
impaired clearance is likely to determine conformational and
structural heterogeneity of mature cIII2, thus accounting for the
aberrant electrophoretic mobility of the complex shown in 1D-
BNGE. This in turn is associated with impaired cIII2 catalytic acti-
vity and increased ROS production. One possibility is that the
persistence of UQCRFS1-derived fragments may prevent newlyM
imported UQCRFS1 precursor to be pro-
cessed/assembled into cIII2, as suggested
by the lower amounts ofmatureUQCRFS1
incorporated in cIII2 from Ttc19
/ tissues.
These findings, together with the kinetic
and steady-state data, show that in physi-
ological conditions the small UQCRFS1-
derived fragments are cleared from thecIII2 holocomplex, which indicates a role for the N-terminal part
of UQCRFS1 in the regulation of cIII2 function as well as a related
quality control function for TTC19.
Our in organello import, quantitative mass spectrometry anal-
ysis, and co-immunoprecipitation assays clearly demonstrate
that TTC19 physically interacts with cIII2 and with cIII2-contain-
ing SCs (cIII2 + cIV and cI + cIII2 + cIV). In addition, using a set
of suitable human cell models, in which UQCRFS1 incorporation
is impaired, as well as kinetic experiments, we have shown that
TTC19 is incorporated into cIII2 species only after its assembly is
completed, i.e., after the incorporation of the last catalytic sub-
unit, UQCRFS1. The assembly of cIII2 proceeds normally in the
absence of TTC19, as shown in the patient-derived fibroblasts
and in Ttc19/ mouse mitochondria. This is compatible with a
role for TTC19 in removing the N-terminal products of UQCRFS1
processing in situ, once it is assembled.
Our results demonstrate that mitochondria of pluricellular
animals have developed a system in which TTC19 acts as a
husbandry factor involved in the clearance of theUQCRFS1 frag-
ments, whose presence within the cIII2 structure is detrimental
for its catalytic activity. TTC19 could be acting in collaboration
with mitochondrial proteases to get rid of the UQCRFS1-pro-
cessed peptides (see the model proposed in Figure 7). In line
with this idea, we found an interaction of TTC19 with the compo-
nents of the recently discovered large inner membrane protease
complex SLP2-PARL-YME1L (SPY) (Wai et al., 2016). Whether
all these factors collaborate together in a specific cIII2 quality
control pathway is a matter of great interest that will be further
investigated.
In conclusion, we propose that the main role of TTC19 is to
preserve the structural and functional integrity of cIII2 and the
lack of this post-assembly quality control role causes cIII2 defi-
ciency, increased ROS production, and organ failure.
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Nogueira, C., Barros, J., Sá, M.J., Azevedo, L., Taipa, R., Torraco, A.,
Meschini, M.C., Verrigni, D., Nesti, C., Rizza, T., et al. (2013). Novel TTC19
mutation in a family with severe psychiatric manifestations and complex III
deficiency. Neurogenetics 14, 153–160.
Ramos-Arroyo, M.A., Hualde, J., Ayechu, A., DeMeirleir, L., Seneca, S., Nadal,
N., and Briones, P. (2009). Clinical and biochemical spectrum of mitochondrialcomplex III deficiency caused by mutations in the BCS1L gene. Clin. Genet.
75, 585–587.
Salmon, P., Oberholzer, J., Occhiodoro, T., Morel, P., Lou, J., and Trono, D.
(2000). Reversible immortalization of human primary cells by lentivector-medi-
ated transfer of specific genes. Mol. Ther. 2, 404–414.
Sánchez, E., Lobo, T., Fox, J.L., Zeviani, M., Winge, D.R., and Fernández-
Vizarra, E. (2013). LYRM7/MZM1L is a UQCRFS1 chaperone involved in the
last steps of mitochondrial complex III assembly in human cells. Biochim.
Biophys. Acta 1827, 285–293.
Sch€agger, H., Borchart, U., Aquila, H., Link, T.A., and von Jagow, G. (1985).
Isolation and amino acid sequence of the smallest subunit of beef heart bc1
complex. FEBS Lett. 190, 89–94.
Schindelin, J., Arganda-Carreras, I., Frise, E., Kaynig, V., Longair, M., Pietzsch,
T., Preibisch, S., Rueden, C., Saalfeld, S., Schmid, B., et al. (2012). Fiji: an
open-source platform for biological-image analysis. Nat. Methods 9, 676–682.
Sciacco, M., and Bonilla, E. (1996). Cytochemistry and immunocytochemistry
of mitochondria in tissue sections. Methods Enzymol. 264, 509–521.
Skarnes, W.C., Rosen, B., West, A.P., Koutsourakis, M., Bushell, W., Iyer, V.,
Mujica, A.O., Thomas, M., Harrow, J., Cox, T., et al. (2011). A conditional
knockout resource for the genome-wide study of mouse gene function.
Nature 474, 337–342.
Smith, P.M., Fox, J.L., and Winge, D.R. (2012). Biogenesis of the cytochrome
bc(1) complex and role of assembly factors. Biochim. Biophys. Acta 1817,
276–286.
Song, M., Chen, Y., Gong, G., Murphy, E., Rabinovitch, P.S., and Dorn, G.W.,
2nd (2014). Super-suppression of mitochondrial reactive oxygen species
signaling impairs compensatory autophagy in primary mitophagic cardiomy-
opathy. Circ. Res. 115, 348–353.
Tucker, E.J., Wanschers, B.F., Szklarczyk, R., Mountford, H.S., Wijeyeratne,
X.W., van den Brand, M.A., Leenders, A.M., Rodenburg, R.J., Reljic, B.,
Compton, A.G., et al. (2013). Mutations in the UQCC1-interacting protein,
UQCC2, cause human complex III deficiency associated with perturbed cyto-
chrome b protein expression. PLoS Genet. 9, e1004034.
Tyanova, S., Temu, T., Sinitcyn, P., Carlson, A., Hein, M.Y., Geiger, T., Mann,
M., and Cox, J. (2016). The Perseus computational platform for comprehen-
sive analysis of (prote)omics data. Nat. Methods 13, 731–740.
Ugalde, C., Vogel, R., Huijbens, R., Van Den Heuvel, B., Smeitink, J., and
Nijtmans, L. (2004). Human mitochondrial complex I assembles through the
combination of evolutionary conserved modules: a framework to interpret
complex I deficiencies. Hum. Mol. Genet. 13, 2461–2472.
Wai, T., Saita, S., Nolte, H., M€uller, S., König, T., Richter-Dennerlein, R.,
Sprenger, H.G., Madrenas, J., M€uhlmeister, M., Brandt, U., et al. (2016). The
membrane scaffold SLP2 anchors a proteolytic hub inmitochondria containing
PARL and the i-AAA protease YME1L. EMBO Rep. 17, 1844–1856.
Wanschers, B.F., Szklarczyk, R., van den Brand, M.A., Jonckheere, A.,
Suijskens, J., Smeets, R., Rodenburg, R.J., Stephan, K., Helland, I.B.,
Elkamil, A., et al. (2014). A mutation in the human CBP4 ortholog UQCC3 im-
pairs complex III assembly, activity, and cytochrome b stability. Hum. Mol.
Genet. 23, 6356–6365.
Wittig, I., Braun, H.P., and Sch€agger, H. (2006). Blue native PAGE. Nat. Protoc.
1, 418–428.
Wittig, I., Karas, M., and Sch€agger, H. (2007). High resolution clear native elec-
trophoresis for in-gel functional assays and fluorescence studies of membrane
protein complexes. Mol. Cell. Proteomics 6, 1215–1225.
Xiao, W., Chirmule, N., Berta, S.C., McCullough, B., Gao, G., and Wilson, J.M.
(1999). Gene therapy vectors based on adeno-associated virus type 1. J. Virol.
73, 3994–4003.
Zara, V., Conte, L., and Trumpower, B.L. (2009). Biogenesis of the yeast cyto-
chrome bc1 complex. Biochim. Biophys. Acta 1793, 89–96.Molecular Cell 67, 96–105, July 6, 2017 105
STAR+METHODSKEY RESOURCES TABLEREAGENT or RESOURCE SOURCE IDENTIFIER
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Mouse monoclonal anti-UQCRFS1 Abcam Cat#ab14746; RRID: AB_301445
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n-dodecyl-b-d-maltoside (DDM) Thermo Scientific Cat#89903
Digitonin, High Purity Calbiochem Cat#300410-5GM
Lipofectamine 2000 Invitrogen Cat#1168019
Blasticidin InvivoGen Cat#ant-bl-1
Hygromycin B InvivoGen Cat#ant-hg-5
Doxycyclin hyclate Sigma Cat#D9891-1G
Hematoxylin solution according to Mayer Sigma Cat#51275-1L
Eosin Y Sigma Cat#E4009-25G
Cresyl Violet acetate Sigma Cat#C5042-10G
Critical Commercial Assays
Dako REAL Detection System, Peroxidase/DAB+, Rabbit/Mouse Dako Cat#K5001
DeadEnd Colorimetric TUNEL System Promega Cat#G7360
(Continued on next page)
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FLUORO-JADE B Millipore Cat#AG310-30MG
Amplex Red Hydrogen Peroxide/Peroxidase Assay Kit Invitrogen Cat#A22188
TNT T7 Quick Coupled Transcription/Translation System Promega Cat#L1170
Experimental Models: Cell Lines
TTC19 patient skin fibroblasts Ghezzi et al., 2011 N/A
BCS1L patient skin fibroblasts Fernandez-Vizarra et al., 2007 N/A
HeLa LYRM7(MZM1L)-HA Sánchez et al., 2013 N/A
Flp-In T-REx 293 Cell Line Invitrogen Cat#R78007







C57BL/6N mice Charles River Laboratories http://www.criver.com/files/pdfs/rms/
c57bl6/rm_rm_d_c57bl6n_mouse.aspx
Oligonucleotides
Uqcrfs1-Fw: 50-TGGTTTGAGCAGCTGTCGCC-30 Raquel Moreno-Loshuertos
(U. Zaragoza, Spain)
N/A
Uqcrfs1-Rv: 50- AGGCCCTGAGTCCACGTGT-30 Raquel Moreno-Loshuertos
(U. Zaragoza, Spain)
N/A
Uqcrb-Fw: 50-CGCTTCACTCTCAGGTCAAA-30 Raquel Moreno-Loshuertos
(U. Zaragoza, Spain)
N/A
















pLOX-Ttag-ires-TK Salmon et al., 2000 Addgene #12246
pSPAX2 Didier Trono Addgene #12260
pMD2.G Didier Trono Addgene #12259
Ptnt Promega Cat#L5610; GenBank: AF479322
pCDNA 5/FRT/TO Invitrogen Cat#V6520-20
Uqcrfs1/pTNT Fernández-Vizarra et al., 2010 N/A
Uqcrb/pTNT This work N/A
hTTC19/pTNT This work N/A
hTTC196His/pTNT This work N/A
hTTC19FLAG/pCDNA 5/FRT/TO This work N/A
Software and Algorithms
SPSS IBM v.19
GraphPad Prism GraphPad Software v.5.0a
MaxQuant Cox and Mann, 2008 http://www.biochem.mpg.de/5111795/
maxquant
(Continued on next page)
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Perseus Tyanova et al., 2016 http://www.biochem.mpg.de/5111810/
perseus
Fiji is just ImageJ Schindelin et al., 2012 https://fiji.sc/
Other
Pre-cast NuPAGE 4%–12% Bis-Tris gels Invitrogen Cat#NP0321BOX; Cat#NP0322BOX;
Cat#NP0326BOX
Pre-cast NativePAGE 3%–12% Bis-Tris gels Invitrogen Cat#BN2011BX10; Cat#BN2012BX10CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Massimo
Zeviani (mdz21@mrc-mbu.cam.ac.uk).
METHOD DETAILS
Cell Culture and Transfection
Human cells were grown in DMEM supplemented with 10% fetal bovine serum, penicillin, and streptomycin in 5% CO2. For the
generation of inducible transgenic TTC19FLAG cell lines, the human cDNA encoding TTC19 plus a C-terminal FLAG (DYKDDDDK)
tag was cloned into the pCDNA 5/FRT/TO vector and transfected with Lipofectamine 2000 into Flp-In T-REx human embryonic
kidney cells. Following transfection, cells were selected with 15 mg/mL Blasticidin and 100 mg/mL hygromycin B. Gene expression
was induced by adding doxycycline to a final concentration of 10 ng/mL for 24 hr.
BNGE
Blue-Native Gel Electrophoresis (BNGE) was performed as described (Nijtmans et al., 2002; Wittig et al., 2006). Mitochondria were
solubilized either with n-dodecyl-b-d-maltoside (DDM) 1.6 mg/mg of mitochondrial protein or digitonin 4mg/mg of mitochondrial
protein (Wittig et al., 2007). Samples were electrophoresed using pre-cast NativePAGE 3%–12% Bis-Tris gels.
Western Blot
Total cell and tissue lysates were separated by denaturing NuPAGE 4%–12% Bis-Tris gels.
In Organello Import of Radiolabeled Proteins
The import and incorporation into cIII2 of radiolabeled human TTC19, TTC19
6His, and mouse Uqcrfs1 and Uqcrb was performed as
described (Fernández-Vizarra et al., 2010).
Generation of Ttc19–/– Mice
All procedures were conducted under the UK Animals (Scientific Procedures) Act, 1986, approved by Home Office license (PPL:
7538) and local ethical review. C57BL/6N-A/a targeted ES cells (agouti) were obtained from the EUCOMM consortium. The targeting
vector was produced using a KO first allele (reporter-tagged insertion with conditional potential) strategy (Skarnes et al., 2011), with
loxP sites surrounding exon 7, encoding the second tetratricopeptide domain, andwhose deletion was predicted to lead to no protein
expression by non-sense mediated decay. ES cells were injected into C57BL/6N blastocysts, and two 90%–100% chimeric males
were obtained. Germline transmission was assessed by backcrossing to C57BL/6N wild-type females and obtained in the 4th litter.
The exon cassette was removed by crossing with a general deleter Cre strain. The animals were maintained on a C57BL/6N back-
ground. The animals were maintained in a temperature- and humidity-controlled animal-care facility with a 12 hr light/dark cycle and
free access to water and food and were sacrificed by cervical dislocation.
Behavioral and Locomotor Analysis
All tests for the assessment of the described parameters were performed according to (Brunetti et al., 2016).
Construction of AAV2/8 Vector
AAV2/8-TBG-hTTC19HIS vector was produced by the AAV Vector Core of the Telethon Institute of Genetics and Medicine (Naples,
Italy) by triple transfection of 293T cells and purified by CsCl gradients (Xiao et al., 1999). Physical titers of the viral preparations
(genome copies per mL) were determined by real-time PCR (Gao et al., 2000) and dot-blot analysis.e3 Molecular Cell 67, 96–105.e1–e4, July 6, 2017
Biochemical Analysis of MRC Complexes
Brain and skeletal muscle samples were snap-frozen in liquid nitrogen and homogenized in 10 mM phosphate buffer (pH 7.4). The
spectrophotometric activity of CI, CII, CIII, and CIV, as well as CS, was measured as described, with slight modifications (Kirby
et al., 2007).
Morphological Analysis
For histochemical analysis, tissues were frozen isopentane pre-cooled in liquid-nitrogen. Eight mm-thick sections were stained for
COX and SDH, as described (Sciacco and Bonilla, 1996). For histological and immunohistochemical analyses, mice were anesthe-
tizedwith an overdose of pentobarbital and perfusedwith PBS followed by 4%PFA. Brains were dissected and post fixed in 4%PFA.
Whole brains were cut along the sagittal plane and embedded in paraffin. Six mm-thick sections were used for analysis. Hematoxylin-
eosin and Nissl staining were performed by standard methods. Immunohistochemistry was performed using specific antibodies
against the indicated proteins. TUNEL assay was performed to label apoptotic cells and Fluoro Jade B stain to label degenerating
neurons.
ROS Measurement
ROS production in isolated mitochondria without any addition of exogenous substrates (Manczak et al., 2006; Song et al., 2014) was
detected by fluorimetric assay using Amplex Red Hydrogen Peroxide/Peroxidase Assay Kit (Invitrogen) according to manufacturer’s
instructions.
Proteomics
Quantitative mass spectrometry analyses with SILAC were performed as described (Andrews et al., 2013) except that a Q-Exactive+
mass spectrometer (Thermo Fisher) was used in these analyses. Each quantitative comparison was performed in duplicate with
reciprocal protein labeling orientations, by growth in media containing heavy and light isotopically labeled arginine and lysine resi-
dues. Complexome analysis of samples excised from Blue Native gels was carried out according to (Heide et al., 2012).
Statistical Analysis
All numerical data are expressed as mean ± SEM. After assessment for normality Student’s unpaired two-tail t test was used for
statistical analysis. Differences were considered statistically significant for p % 0.05.Molecular Cell 67, 96–105.e1–e4, July 6, 2017 e4
